259 related articles for article (PubMed ID: 24442600)
1. The role of SPECT/CT in radioembolization of liver tumours.
Ahmadzadehfar H; Duan H; Haug AR; Walrand S; Hoffmann M
Eur J Nucl Med Mol Imaging; 2014 May; 41 Suppl 1():S115-24. PubMed ID: 24442600
[TBL] [Abstract][Full Text] [Related]
2. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
[TBL] [Abstract][Full Text] [Related]
3. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
[TBL] [Abstract][Full Text] [Related]
4. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Todica A; Bartenstein P; Hacker M; Haug AR
J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830
[TBL] [Abstract][Full Text] [Related]
6. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
[TBL] [Abstract][Full Text] [Related]
7. Intraarterial Hepatic SPECT/CT Imaging Using 99mTc-Macroaggregated Albumin in Preparation for Radioembolization.
Gates VL; Singh N; Lewandowski RJ; Spies S; Salem R
J Nucl Med; 2015 Aug; 56(8):1157-62. PubMed ID: 26089551
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of imaging
Kunnen B; Dietze MMA; Braat AJAT; Lam MGEH; Viergever MA; de Jong HWAM
Med Phys; 2020 Mar; 47(3):1105-1114. PubMed ID: 31855282
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-MAA/ 90Y-Bremsstrahlung SPECT/CT after simultaneous Tc-MAA/90Y-microsphere injection for immediate treatment monitoring and further therapy planning for radioembolization.
Ahmadzadehfar H; Sabet A; Muckle M; Wilhelm K; Reichmann K; Biersack HJ; Ezziddin S
Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1281-8. PubMed ID: 21359611
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors.
Bilbao JI; Garrastachu P; Herráiz MJ; Rodríguez M; Iñarrairaegui M; Rodríguez J; Hernández C; de la Cuesta AM; Arbizu J; Sangro B
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):523-31. PubMed ID: 19841973
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours.
Meyer C; Pieper CC; Ezziddin S; Wilhelm KE; Schild HH; Ahmadzadehfar H
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):231-7. PubMed ID: 24030669
[TBL] [Abstract][Full Text] [Related]
12. 3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates.
Brosch J; Gosewisch A; Kaiser L; Seidensticker M; Ricke J; Zellmer J; Bartenstein P; Ziegler S; Ilhan H; Todica A; Böning G
Phys Med; 2020 Dec; 80():317-326. PubMed ID: 33248338
[TBL] [Abstract][Full Text] [Related]
13.
Debebe SA; Adjouadi M; Gulec SA; Franquiz J; McGoron AJ
J Appl Clin Med Phys; 2019 Feb; 20(2):30-42. PubMed ID: 30628156
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.
Wondergem M; Smits ML; Elschot M; de Jong HW; Verkooijen HM; van den Bosch MA; Nijsen JF; Lam MG
J Nucl Med; 2013 Aug; 54(8):1294-301. PubMed ID: 23749996
[TBL] [Abstract][Full Text] [Related]
15. Accuracy and reproducibility of a cone beam CT-based virtual parenchymal perfusion algorithm in the prediction of SPECT/CT anatomical and volumetric results during the planification of radioembolization for HCC.
Derbel H; Krichen M; Chalaye J; Saccenti L; Van der Sterren W; Muris AH; Lerman L; Galletto A; Zaarour Y; Luciani A; Kobeiter H; Tacher V
Eur Radiol; 2023 May; 33(5):3510-3520. PubMed ID: 36651956
[TBL] [Abstract][Full Text] [Related]
16. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792
[TBL] [Abstract][Full Text] [Related]
17. Quantitative comparison of pre-therapy
Knešaurek K; Tuli A; Pasik SD; Heiba S; Kostakoglu L
Eur J Radiol; 2018 Dec; 109():57-61. PubMed ID: 30527312
[TBL] [Abstract][Full Text] [Related]
18. Comparison of perfused volume segmentation between cone-beam CT and
Martin M; Hocquelet A; Debordeaux F; Bordenave L; Blanc JF; Papadopoulos P; Lapuyade B; Trillaud H; Pinaquy JB
Diagn Interv Imaging; 2021 Jan; 102(1):45-52. PubMed ID: 33032960
[TBL] [Abstract][Full Text] [Related]
19. Measurement of the Tumor-to-Normal Ratio for Radioembolization of Hepatocellular Carcinoma: A Prospective Study Comparing 2-Dimensional Perfusion Angiography, Technetium-99m Macroaggregated Albumin, and Yttrium-90 SPECT/CT.
Brunson CP; McGregor HJ; Hennemeyer CT; Patel MV; Woodhead GJ; Young SJ
J Vasc Interv Radiol; 2024 Jan; 35(1):94-101. PubMed ID: 37783268
[TBL] [Abstract][Full Text] [Related]
20. Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases.
Kousik V; Promila P; Verma R; Gupta A
Indian J Gastroenterol; 2016 May; 35(3):179-85. PubMed ID: 27185180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
